Drug Profile
BCTP
Latest Information Update: 28 Nov 2006
Price :
$50
*
At a glance
- Originator Novavax
- Class Antibacterials; Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections